High density lipoproteins and atherosclerosis: emerging aspects
- PMID: 23341845
- PMCID: PMC3545258
- DOI: 10.3724/SP.J.1263.2011.12282
High density lipoproteins and atherosclerosis: emerging aspects
Abstract
High density lipoproteins (HDL) promote the efflux of excess cholesterol from peripheral tissues to the liver for excretion. This ability is responsible for the most relevant anti-atherogenic effect of HDL. The ability of HDL to promote cholesterol efflux results also in the modulation of a series of responses in the immune cells involved in atherosclerosis, including monocyte-macrophages, B and T lymphocytes. Furthermore, during inflammation, the composition of this class of lipoproteins varies to a large extent, thus promoting the formation of dysfunctional HDL. The aim of this review is to discuss the emerging role of HDL in modulating the activity of immune cells and immune-inflammatory mediators during atherogenesis.
Keywords: Apolipoprotein; High density lipoproteins; Immune response; Sphingosine-1-phosphate.
Similar articles
-
HDLs, immunity, and atherosclerosis.Curr Opin Lipidol. 2011 Oct;22(5):410-6. doi: 10.1097/MOL.0b013e32834adac3. Curr Opin Lipidol. 2011. PMID: 21881500 Review.
-
Emerging role of high density lipoproteins as a player in the immune system.Atherosclerosis. 2012 Jan;220(1):11-21. doi: 10.1016/j.atherosclerosis.2011.06.045. Epub 2011 Jul 2. Atherosclerosis. 2012. PMID: 21783193 Review.
-
Dysfunctional High-Density Lipoproteins Are Associated With a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk: A Nested Case-Control Study.Circulation. 2020 Feb 11;141(6):444-453. doi: 10.1161/CIRCULATIONAHA.119.041658. Epub 2020 Jan 16. Circulation. 2020. PMID: 31941372 Clinical Trial.
-
[Dysfunctional High-Density Lipoproteins: Role in Atherogenesis and Potential Targets for Phospholipid Therapy].Kardiologiia. 2018 Mar;(3):73-83. Kardiologiia. 2018. PMID: 29782274 Review. Russian.
-
High density lipoprotein biogenesis, cholesterol efflux, and immune cell function.Arterioscler Thromb Vasc Biol. 2012 Nov;32(11):2561-5. doi: 10.1161/ATVBAHA.112.300135. Arterioscler Thromb Vasc Biol. 2012. PMID: 23077142 Free PMC article. Review.
Cited by
-
The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis.Int J Mol Sci. 2019 Jul 20;20(14):3561. doi: 10.3390/ijms20143561. Int J Mol Sci. 2019. PMID: 31330845 Free PMC article. Review.
-
Nonesterified fatty acids and spontaneous preterm birth: a factor analysis for identification of risk patterns.Am J Epidemiol. 2014 May 15;179(10):1208-15. doi: 10.1093/aje/kwu037. Epub 2014 Apr 8. Am J Epidemiol. 2014. PMID: 24714724 Free PMC article.
-
HDL: to treat or not to treat?Curr Atheroscler Rep. 2014 Aug;16(8):429. doi: 10.1007/s11883-014-0429-x. Curr Atheroscler Rep. 2014. PMID: 24890632 Review.
-
High density lipoprotein promotes proliferation of adipose-derived stem cells via S1P1 receptor and Akt, ERK1/2 signal pathways.Stem Cell Res Ther. 2015 May 15;6(1):95. doi: 10.1186/s13287-015-0090-5. Stem Cell Res Ther. 2015. PMID: 25976318 Free PMC article.
-
The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism.Biomed Res Int. 2013;2013:836790. doi: 10.1155/2013/836790. Epub 2013 Nov 12. Biomed Res Int. 2013. PMID: 24319689 Free PMC article. Review.
References
-
- Glass CK, Witztum JL. Atherosclerosis. the road ahead. Cell. 2001;104:503–516. - PubMed
-
- Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011;12:204–212. - PubMed
-
- Navab M, Ananthramaiah GM, Reddy ST, et al. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res. 2004;45:993–1007. - PubMed
-
- von Eckardstein A, Nofer JR, Assmann G. High density lipoproteins and arteriosclerosis. Arterioscler Thromb Vasc Biol. 2001;21:13–27. Role of cholesterol efflux and reverse cholesterol transport. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources